In our previous work, we clearly demonstrate that priming with interleukin-1 alpha (IL-1α) drives the MSC secretome towards a more anti-inflammatory and pro-trophic phenotype which may translate into a better therapy for ischaemic stroke [17]. This evidence concerns the gene IL1A and ischemic stroke.